Dr. Scott Tyldesley of UBC reports on 15-year ASCENDE-RT data: Brachytherapy boost halves PC-specific mortality (8.6% vs 16.4%, P=.007) but shows no OS benefit.

Read more here: ➡️ https://bit.ly/3OGoIaH

#pcsm #prostatecancer #ASCOGU26 #GU26

This morning, Dr. Zachary Yochum presented research on cell-of-origin analysis for #renalcellcarcinoma. For this research, Dr. Yochum was awarded a #ConquerCancer Merit Award which recognizes outstanding research in abstracts at #ASCOGU26.
meetings.asco.org/meetings/2026-…
@braunmdphd.bsky.social

At #ASCOGU26: @danafarber.bsky.social’s Dr. Brad McGregor provides an update on the STRIKE! clinical trial which looks at short term intensified pembrolizumab and tivozanib for high-risk renal cell carcinoma.

Thank you to Taigo Kato, MD, PhD, who participated in an interview to discuss the MONSTAR-SCREEN-3 study. Stay tuned to onclive.com for all of our coverage of @ascocancer.bsky.social #GU26 #ASCOGU26 #oncology

At 11:30am PST, Dr. Daniel Petrylak presents results of a QI initiative on 1st line combination therapy + biomarker testing in #urothelialcarcinoma in community settings. #ASCOGU26
meetings.asco.org/meetings/202...

Eli Van Allen, MD, of Dana-Farber Cancer Institute

Reimagining Cancer Research and Care in the Age of Artificial Intelligence: @danafarbernews.bsky.social’s Eli Van Allen, MD, delivers this keynote presentation at #ASCOGU26 today at 2:15pm PT/11:15am ET.

In the Trials in Progress Poster Session A starting at 11:30am PST #ASCOGU26, Dr. Daniel Petrylak shares an update on the LuxAR-02 Phase II study for PSMA-positive metastatic castration resistant #prostatecancer. meetings.asco.org/meetings/202...

It's day one of #ASCOGU26, and starting at 11:30am PST,
@mleapman.bsky.social will present two posters during Poster Session A on #prostatecancer. meetings.asco.org/meetings/202...
@carygross.bsky.social

✨ Meet Kevin Bambury at ASCO #GU2026 representing ONCOassist!

Attending ASCO GU? Let’s connect.

#ASCOGU26 #Oncology #CancerCare #DigitalHealth #MedTech #ONCOassist

Dr. Eliezer M. Van Allen to Deliver ASCO GU26 Keynote on Reimagining Cancer Research and Care in the AI Age Clinical computational oncologist Dr. Eliezer M. Van Allen will deliver the keynote address at the 2026 ASCO Genitourinary Cancers Symposium, where he will discuss the latest research on and developme...

Cancer care and AI: Dr. Eli Van Allen will deliver the #ASCOGU26 keynote address on “Reimagining Cancer Research and Care in the AI Age.”

Read more in The @ascopost.bsky.social ➡️ bit.ly/4rQChTp

ASCO Calls for Final Abstract Submissions for ASCO GU 26 - OncoDaily ASCO Calls for Final Abstract Submissions for ASCO GU 26 / ASCO, cancer, OncoDaily, Oncology

ASCO Calls for Final Abstract Submissions for ASCO GU 26

@ascocancer.bsky.social

oncodaily.com/voices/asco-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO #ASCOGU26

Eric Small: Registration is Open for the Premier 2026 ASCO GU Meeting in San Francisco - OncoDaily Eric Small: Registration is Open for the Premier 2026 ASCO GU Meeting in San Francisco / 2026 ASCO, ASCO Genitourinary Cancers, cancer, Eric Small, GU

Registration is Open for the Premier 2026 ASCO GU Meeting in San Francisco - Eric Small

@ascocancer.bsky.social @ericsmall.bsky.social

oncodaily.com/voices/eric-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO #ASCOGU26